Pancreatic Cancer Research

ResearcherAlbert Einstein College of MedicineNo recent work listed

Ekaterina Dadachova

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7300-6479; OpenAlex author ID A5034610205; NIH RePORTER profile ID 6878566. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
1
Labs led
1
Collaborators
8
Papers, trials and grants by year

2012: 1 grant · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper

Papers 5

  1. Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer. Last author DOI 10.1002/cam4.2379↗
  2. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect. Co-author DOI 10.18632/oncotarget.15117↗
  3. Targeted radionuclide therapies for pancreatic cancer. Last author DOI 10.1038/cgt.2015.32↗
  4. Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA. Last author DOI 10.1586/14737140.2014.952285↗
  5. Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer. Co-author DOI 10.1073/pnas.1211287110↗

Grants 1

  1. Targeted therapy of pancreatic cancer with in vivo radionuclide generator R21CA156088↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Claudia Gravekamp · 3 shared papers, 2013–2017 · strength 0.17
  2. Ruth A. Bryan · 2 shared papers, 2014–2019 · strength 0.13
  3. Dinesh Chandra · 2 shared papers, 2013–2017 · strength 0.11
  4. Rubin Jiao · 1 shared paper, 2019 · strength 0.09
  5. Benson Chellakkan Selvanesan · 1 shared paper, 2017 · strength 0.07
  6. M Shah · 1 shared paper, 2015 · strength 0.06
  7. Julius Strauss · 1 shared paper, 2014 · strength 0.04
  8. Wilber Quispe‐Tintaya · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.